ICAM2
ICAM2 (intercellular adhesion molecule 2, also known as CD102) is a type I transmembrane glycoprotein of the immunoglobulin superfamily. It acts as a receptor ligand for LFA-1 and CD209, mediating adhesive interactions that support immune response and surveillance. Browse Assay Genie's current range of ICAM2 research reagents below, or read on for the biology behind the target.
ICAM2 is a cell adhesion molecule that functions as a receptor ligand of the signalling receptor ITGAL:ITGB2, also known as LFA-1 (lymphocyte function-associated molecule 1), ensuring leukocyte cell-cell adhesion on resting cells. It is also an endothelial blood vessel ligand for the dendritic cell receptor CD209, and this interaction triggers transendothelial migration of dendritic cell precursors from blood into peripheral tissues and, subsequently, into lymphoid tissues. Through these contacts, ICAM2 mediates adhesive interactions important for antigen presentation, lymphocyte recirculation and other cellular interactions in immune response and surveillance.
The ICAM2 gene encodes a member of the intercellular adhesion molecule (ICAM) family. All ICAM proteins are type I transmembrane glycoproteins, contain 2-9 immunoglobulin-like C2-type domains, and bind the leukocyte adhesion protein LFA-1. The ICAM2 protein localises to the cell membrane and to microvilli, and several transcript variants of the gene encode the same protein. HGNC classes it among CD molecules, receptor ligands, immunoglobulin-like domain containing proteins and the Ig-like cell adhesion molecule family. The mouse ortholog is Icam2.
Functionally, ICAM2 may contribute to lymphocyte recirculation by blocking LFA-1-dependent cell adhesion. It is also described as mediating adhesive interactions important for antigen-specific immune responses and NK-cell mediated clearance. Its relationship to other ICAM family members, such as ICAM-1, ICAM3, ICAM4 and ICAM5, makes it a useful reference point when studying integrin-ligand adhesion in the immune system.
ICAM2 is a receptor ligand of LFA-1 that ensures leukocyte cell-cell adhesion on resting cells.
As an endothelial ligand of CD209, ICAM2 triggers transendothelial migration of dendritic cell precursors from blood into peripheral and lymphoid tissues.
ICAM2 may play a role in lymphocyte recirculation by blocking LFA-1-dependent cell adhesion.
ICAM2 mediates adhesive interactions important for antigen presentation, NK-cell mediated clearance and immune surveillance.
ICAM2 is a cell adhesion molecule and receptor ligand for LFA-1 and CD209. It supports leukocyte cell-cell adhesion, dendritic cell precursor migration across endothelium, and interactions involved in antigen presentation, lymphocyte recirculation and immune surveillance.
ICAM2 is also called CD102, and its full name is intercellular adhesion molecule 2. HGNC lists no previous names. Several transcript variants of the gene have been found, and all of them encode the same protein.
A mouse ortholog, Icam2, is recorded for the human gene. ICAM2 belongs to the ICAM family of the immunoglobulin superfamily, alongside ICAM-1, ICAM3, ICAM4 and ICAM5. Check the datasheet of any product for its validated reactivity.
Other ICAM family members and partner receptors involved in leukocyte adhesion and immune surveillance.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P13598; product specifications from Assay Genie datasheets.